tiprankstipranks

Gerald Cagle Insider Profile

4 Followers
Gerald Cagle, Director at Aerie Pharma, holds 20.05K shares in Aerie Pharma (Ticker: AERI), holds 3.32K shares in CalciMedica (Ticker: CALC), holds 94.21K shares in Clearside Biomedical (Ticker: CLSD).
tipranks
Gerald Cagle

Gerald Cagle
Aerie Pharma (AERI)
Director

Ranked #83,399 out of 98,501 Corporate Insiders

Profitable Transactions

27%
3 out of 11 Profitable Transactions

Average Return

-16.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$132K
89.61%
10.39%
A breakdown of Gerald Cagle's holdings

Insider Roles

Clearside Biomedical
(CLSD)
Director
CalciMedica
(CALC)
Director
Roles that Gerald Cagle holds in companies

Most Profitable Insider Trade

Stock:
Aerie Pharma
(AERI)
Rating:Informative Buy
Date:Apr 26, 2016 - Apr 26, 2017
Return:+159.30%
The most profitable trade made by Gerald Cagle

Gerald Cagle's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AERI
Aerie Pharma
Jun 21, 2021
Uninformative Buy
$305.76K
Clearside Biomedical
Jun 26, 2018
Director
Informative Buy
99.90K
$118.70K
CalciMedica
Sep 29, 2020
Director
Uninformative Buy
$13.77K
List of latest transactions for each holding click on a transaction to see Gerald Cagle's performance on stock

Gerald Cagle insider profile FAQ

What is the percentage of profitable transactions made by Gerald Cagle?
The percentage of profitable transactions made by Gerald Cagle is 27%.
    What is the average return per transaction made by Gerald Cagle?
    The average return per transaction made by Gerald Cagle is -16.80%.
      What stocks does Gerald Cagle hold?
      Gerald Cagle holds: AERI, CLSD, CALC stocks.
        What was Gerald Cagle’s latest transaction?
        Gerald Cagle latest transaction was an Uninformative Buy of ―.
          What was Gerald Cagle's most profitable transaction?
          Gerald Cagle’s most profitable transaction was an Informative Buy of AERI stock on April 26, 2016. The return on the trade was 159.30%.
            What is Gerald Cagle's role in Aerie Pharma?
            Gerald Cagle's role in Aerie Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.